An analysis of how polarized light interacts with clumps of proteins in the eyes may help differentiate amyotrophic lateral…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A Phase 2 clinical trial showed that early treatment with the experimental oral therapy PrimeC slowed functional decline and reduced…
A brain implant to detect attempted finger movements can enable people paralyzed by conditions such as amyotrophic lateral sclerosis…
Insmed has launched a first-in-human clinical trial evaluating its experimental gene therapy INS1202 in people with amyotrophic lateral…
An experimental nerve-protecting therapy called RT1999 (smilagenin) will soon be tested in people with amyotrophic lateral sclerosis (ALS)…
People with amyotrophic lateral sclerosis (ALS) who were exposed to smoke from wildfires prior to developing the disease are…
The ALS Network will continue to host its ASK ME…
A specific alteration in the TDP-43 protein can reduce the viability of nerve cells in a lab model of amyotrophic…
Early birds — people with a natural tendency to wake up and go to sleep at earlier times — are…
The amyotrophic lateral sclerosis (ALS) community is mourning the loss of Eric Dane, the “Grey’s Anatomy” star who turned…